Nov 13, 2020
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $1.05 to $0.07.
The split itself did not change the total investment value.
Viridian Therapeutics, Inc. (VRDN) trades on the NASDAQ Capital Market in the Biotechnology industry.
Viridian Therapeutics, Inc. company overviewThe latest split shown was on November 13, 2020. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records 2 reverse splits between November 7, 2016 and November 13, 2020.